IBM announced plans to acquire Phytel at HIMSS15 as part of its introduction of IBM Watson Health, the company’s new dedicated healthcare arm.
Financial terms of the acquisition were not disclosed.
“The acquisition of Phytel supports our goal to advance the quality and effectiveness of personal healthcare by enabling secure access to individualized insights and a more complete picture of the many factors that can affect people’s health,” said Mike Rhodin, senior vice president of IBM Watson.
More articles on IBM:
Epic, IBM Watson, Mayo Clinic to embed cognitive computing in EHRs
IBM could overpower Amazon when it comes to cloud services
7 things to know about IBM Watson
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
